BCR-ABL1-Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival
Articles > Article · 2021
Authors: Kadriye Bahriye Payzin, Kaan Savasoglu, İNCİ ALACACIOĞLU, Elif Ebru Dalgic, Betul Bolat Kucukzeybek, Aylin Orgen Calli, Sadi Bener, Serdar PAYZIN
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, Journal Indexed in SCI Expanded, International, 2021, vol 21, pp 125-131
DOI: 10.1016/j.clml.2020.08.006
Summary
This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic myeloproliferative neoplasms (CMPNs) and evaluated the impact of PHT on survival during long-term follow-up. In a large group of BCR-ABL1-negative CMPN patients, there was a low prevalence of PHT. The impact of PHT on survival was negligible.